SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019275
Filing Date
2022-05-10
Accepted
2022-05-10 16:11:34
Documents
63
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20220331.htm   iXBRL 10-Q 2287050
2 EX-10.1 arwr-ex101_473.htm EX-10.1 88346
3 EX-31.1 arwr-ex311_10.htm EX-31.1 9856
4 EX-31.2 arwr-ex312_7.htm EX-31.2 10790
5 EX-32.1 arwr-ex321_11.htm EX-32.1 6311
6 EX-32.2 arwr-ex322_8.htm EX-32.2 6556
  Complete submission text file 0001564590-22-019275.txt   7879514

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20220331.xsd EX-101.SCH 55750
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20220331_cal.xml EX-101.CAL 47938
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20220331_def.xml EX-101.DEF 193833
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20220331_lab.xml EX-101.LAB 415363
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20220331_pre.xml EX-101.PRE 335882
57 EXTRACTED XBRL INSTANCE DOCUMENT arwr-10q_20220331_htm.xml XML 1341774
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 22909710
SIC: 2834 Pharmaceutical Preparations